Eyewire News

Featured Story

08.24.2026

Oculis Doses First Patient in Phase 3 PIONEER-1 Trial of Privosegtor for Optic Neuritis

Oculis announced that the first patient has been treated in the PIONEER-1 registrational trial evaluating Privosegtor for acute-onset optic neuritis, marking the start of the company’s late-stage clinical program for the investigational neuroprotective therapy. PIONEER-1 is the first of 2 registrational studies in Oculis’ PIONEER program, or "Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research." The trial is enrolling a broad population of patients with acute-onset optic neuritis, including those with and without multiple sclerosis (MS).

Read Story

Latest News Stories

08.24.2026

SightGlass Vision Reports 2 Million Children Worldwide Have Worn Dot Spectacle Lenses

08.21.2026

NICE Draft Guidance Recommends Against NHS Funding of Low-Dose Atropine for Childhood Myopia

08.21.2026

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

08.20.2026

FDA Expands TearCare's Indication to Include Improvement of Meibomian Gland Function

08.20.2026

Lupin and Tenpoint Announce Strategic Partnership to Commercialize Yuvezzi in Europe

08.19.2026

Eyconis Initiates First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet AMD

Ingenia Therapeutics Goes Public on KOSDAQ Market image

08.19.2026

Ingenia Therapeutics Goes Public on the Korean KOSDAQ Market

Zeiss Clinic 360 Receives FDA 510k Clearance image

08.19.2026

Zeiss Receives FDA 510k Clearance for Zeiss Clinic 360 Cloud-Based Data Management Solution

08.18.2026

New Moorfields Stem Cell Treatment Improves Vision for Aniridia-Related Keratopathy

08.18.2026

Balance Ophthalmics Announces Medicare Pricing for FSYX Ocular Pressure Adjusting Pump

08.18.2026

DefEYE Announces Article Highlighting Use of Decellularized Basement Membrane in Patients with NK

08.17.2026

Duravyu Misses Primary Endpoint in Phase 3 LUGANO Trial but Reduces Treatment Burden in Wet AMD

08.17.2026

CMS Strengthens Prior Authorization Transparency Requirements

08.17.2026

CORE Publishes Contact Lens Update Issue Focused on Presbyopia Communication

08.17.2026

WCO, Alcon, and IACLE Expand Access to Dry Eye Education Tools

08.14.2026

European Consortium Launches Human Trials of Gene-Silencing Eye Drops for Rare Corneal Diseases

08.14.2026

Large UK Study Examines Impact of Anti-VEGF Treatment for DME on Progression to Proliferative Diabetic Retinopathy

08.13.2026

First Patient Receives Investigational Regenerative Cell Therapy for Non-Syndromic Retinitis Pigmentosa

08.13.2026

Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes

Eyewire News

Featured Story

08.24.2026

Oculis Doses First Patient in Phase 3 PIONEER-1 Trial of Privosegtor for Optic Neuritis

Latest News Stories

08.24.2026

SightGlass Vision Reports 2 Million Children Worldwide Have Worn Dot Spectacle Lenses

08.21.2026

NICE Draft Guidance Recommends Against NHS Funding of Low-Dose Atropine for Childhood Myopia

08.21.2026

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

08.20.2026

FDA Expands TearCare's Indication to Include Improvement of Meibomian Gland Function

08.20.2026

Lupin and Tenpoint Announce Strategic Partnership to Commercialize Yuvezzi in Europe

08.19.2026

Eyconis Initiates First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet AMD

08.19.2026

Ingenia Therapeutics Goes Public on the Korean KOSDAQ Market

08.19.2026

Zeiss Receives FDA 510k Clearance for Zeiss Clinic 360 Cloud-Based Data Management Solution

08.18.2026

New Moorfields Stem Cell Treatment Improves Vision for Aniridia-Related Keratopathy

08.18.2026

Balance Ophthalmics Announces Medicare Pricing for FSYX Ocular Pressure Adjusting Pump

08.18.2026

DefEYE Announces Article Highlighting Use of Decellularized Basement Membrane in Patients with NK

08.17.2026

Duravyu Misses Primary Endpoint in Phase 3 LUGANO Trial but Reduces Treatment Burden in Wet AMD

08.17.2026

CMS Strengthens Prior Authorization Transparency Requirements

08.17.2026

CORE Publishes Contact Lens Update Issue Focused on Presbyopia Communication

08.17.2026

WCO, Alcon, and IACLE Expand Access to Dry Eye Education Tools

08.14.2026

European Consortium Launches Human Trials of Gene-Silencing Eye Drops for Rare Corneal Diseases

08.14.2026

Large UK Study Examines Impact of Anti-VEGF Treatment for DME on Progression to Proliferative Diabetic Retinopathy

08.13.2026

First Patient Receives Investigational Regenerative Cell Therapy for Non-Syndromic Retinitis Pigmentosa

08.13.2026

Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes

EyewireTV

08.19.2026

The Latest EyewireTV

Tamara R. Fountain, MD

Zubair Ansari, MD

Michelle Sun, MD, MPH

Stay Updated